Literature DB >> 2728944

[Action of calcium antagonists on ureteral dynamics].

S Salman, C Castilla, R Vela Navarrete.   

Abstract

We have investigated the action, in vivo, of a calcium antagonist on pyelouretheral dynamics. A surgical model consisting of a bilateral subcutaneous nephrostomy was used, which permits repeated studies in the same animal and simultaneous collection from both pyelouretheral tracts. Anterograde perfusion of a 1.5 ml/min flow gives rise to 7.6 +/- 2.3 contractions per minute of variable amplitude between 12.4 +/- 5.6 mm Hg. Verapamil, in intravenous 5-mg application, significantly reduces (P less than 0.05) the number of contractions per minute but does not mitigate or block the stimulus to a subsequent Norepinefrina injection. We conclude that Verapamil has a moderate but significant effect on pyelouretheral dynamics. We comment on the effect that this drug may have on the pyelouretheral tract when used for hemodynamic purposes and on its potential use in various urological affections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2728944

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  4 in total

Review 1.  Ureteric colic: new trends in diagnosis and treatment.

Authors:  M Masarani; M Dinneen
Journal:  Postgrad Med J       Date:  2007-07       Impact factor: 2.401

2.  The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?

Authors:  Riccardo Autorino; Marco De Sio; Rocco Damiano; Giuseppe Di Lorenzo; Sisto Perdonà; Aniello Russo; Giuseppe Quarto; Luca Cosentino; Massimo D'Armiento
Journal:  Urol Res       Date:  2005-11-29

3.  Medical expulsive therapy.

Authors:  Kyle D Wood; Ilya Gorbachinsky; Jorge Gutierrez
Journal:  Indian J Urol       Date:  2014-01

4.  Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin): study protocol for a randomized controlled trial.

Authors:  Sam McClinton; Kathryn Starr; Ruth Thomas; Graeme McLennan; Gladys McPherson; Alison McDonald; Thomas Lam; James N'Dow; Mary Kilonzo; Robert Pickard; Ken Anson; Jennifer Burr
Journal:  Trials       Date:  2014-06-20       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.